Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medtronic financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$90.3
2024-10-29
Market Capitalization
$114.6 B
2024-08-26
Revenue
$32.4 B
FY, 2024
CreditSafe Score
?
Score changed on Mar 20, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|
| Revenue | 31.7B | 31.2B | 32.4B |
| Cost of goods sold | 10.1B | 10.7B | 11.2B |
| Gross profit | 21.5B | 20.5B | 21.1B |
| Gross profit margin, % | 68.0% | 65.7% | 65.3% |
| General and administrative expense | 10.3B | 10.4B | 10.7B |
| Operating expense total | 15.8B | 15.0B | 16.0B |
| Depreciation and amortization | 1.7B | 1.7B | 1.7B |
| EBIT | 5.8B | 5.5B | 5.1B |
| EBIT margin, % | 18.2% | 17.6% | 15.9% |
| Interest expense | 553.0M | 636.0M | 719.0M |
| Pre tax profit | 5.5B | 5.4B | 4.8B |
| Income tax expense | 456.0M | 1.6B | 1.1B |
| Net Income | 5.1B | 3.8B | 3.7B |
| EPS | 3.7 | 2.8 | 2.8 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |